The landscape of COVID-19 treatment continues to evolve in 2025, with a renewed spotlight on repurposed drugs such as Ivermectin USA. Once a controversial candidate, Ivermectin’s role in managing COVID and particularly long-COVID has been the subject of numerous studies across U.S. institutions. However, recent findings present mixed data that have reignited public confusion and...